Oropharingeal candidosis in HIV patients: Antifungal resistance profile;Candidiasis orofaríngeas en pacientes HIV positivos: Perfil de resistencia a antifúngicos

Revista Iberoamericana de Micologia

Volumn 13, Issue 3, 1996, Pages 64-67

  Rodero, L ^a   Boutureira, M ^a   Vivot, W ^a   Canteros, C ^a   Perrota, D ^a   Davel, G ^a  

^a NONE

Author keywords

Antifungal resistance; Antifungals; Oropharingeal candidosis; Yeasts

Indexed keywords

EID: 0006002721     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sobel J Controversial aspects of candidiasis in the Acquired Immunodeficiency Syndrome. En Mycoses in AIDS Patients New york Plenum press. 1990: 93-100
2. Lode H, Höffken G. Oral candidosis and its role in immunocompromised patients Mycoses 1989, 32 30-33
3. Rex J, Rinaldi MG, Pfaller MA Minireview Resistance of Candida species to fluconazol. Antimicrob Agents Chemother 1995; 39:1-8
4. Warnock D Immunological aspects of candidosis in AIDS patients Mycoses in AIDS patients. New York. Plenum Press. 1990 83-91.
5. Rex JH, Pfaller MA, Rinaldi MG, Polack A, Galgiani J Antifungal Susceptibility testing. Clin Microbiol Rev 1993, 6 367-381.
6. Kreeger-van Rij NJW. The Yeasts Amsterdam. 3th Ed Elsevier 1984.
7. Feo M Es̈tudio de las condiciones de formación de las clamidosporas. Rev Lat-Amer Microbiol 1974, 16 105-110
8. Davel G, Nuñez V, Mancebo G Mëtodo de identificación de levaduras basado en sus propiedades bioquímicas y tisiolégicas. V Congreso Argentino de Micología 1991. Sta Fe Argentina
9. Rodero L, Davel G, Vivot W, Canteros C, Fernandez C Pruebas de sensibilidad in vitro para levaduras Evaluación de un micrométodo Rev Arg. de Microbiol (en prensa) 1995 27
10. National Committe for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of yeasts, Proposed Standard. NCCLS Document M27-P12 (25) ; 1992.
11. Odds FC Antifungal susceptibility testing of Yeast Evaluation of Technical Variables for Test Automation. Atimicrob Agents Chemother. 1992, 39 2051-2060.
12. Odds FC Antifungal susceptibility testing of Candida spp by relative growth measurment at single concentrations of antifungal agents. Antimicrob Agents Chemother. 1932; 36 1727-1737.
13. Odds FC Quantitative microculture system with standarized inocula for strain typing. susceptibility testing and other physiologic measurments with Candida albicans and other yeasts. J Clin Microbiol 1991 29: 2735-2740.
14. Odds FC. Resistance of yeasts to azole-derivate antifungals J Antimicrob Chemother 1993, 31: 463-471
15. Ancarani F Incidence and prevalence of Candida non-albicans in oral Candida infections Invasive Mycoses Critical trends, clinical challenges Focus on itraconazole Cannes, France; 1993
16. Just G, Steinheimer D, Schenellbach M, Böttinger C, Helm EB, Stille W Change of causative organisms under antifungal tratment in immunocompromised patients with HIV-Infections Mycoses 1989, 32: 47-51
17. Odds FC Candida infections in AIDS. Int. J STDAIDS 1992, 3. 157-160
18. Just-Nubling G, Gentschew G, Dohle M, Bóttinger C, Helm ED Stille W. Fluconazole in the treatment of oropharingeal candidosis in HIV positive patients Mycoses 1990, 33 435-440
19. Stiller RL, Bennett JE, Scholer HJ, Wall M, Polack A Stevens D Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates frome the United States Antimicrob Agents Chemother 1982; 22 482-487
20. Odds FC, Schimd J, Soll DR. Epidemiology of Candida infections in AIDS Mycoses in AIDS patients New York Plenum Press 1990
21. Johnson EM, Davey KG, Warnock DW In vitro activity of itraconazole against fluconazole-resistant yeasts isolates 34th ICAAC. Orlando. USA 1994, Abstract E70:175